Efficacy of the combination of an α1-blocker with an anticholinergic agent in the treatment of lower urinary tract symptoms associated with bladder outlet obstruction

Bibliography

• GARRAWAY WM, COLLINS GN, LEE RG: High prevalence of benign prostatatic hypertrophy in the community. Lancet (1991) 338:469-471. This is a fine epidemiological study on the prevalence of benign prostatic hyperplasia.
   Google Scholar
• SPEAKMAN MJ: Initial choices and final outcomes in lower urinary tract symptoms. Bur. Urol. (2001) 40(Suppl.):21–30.
   Google Scholar
• LEPOR H, MACHI G: Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology (1993) 42:36–40.
   PubMed Web of Science ®Google Scholar
• ROSIER PF, DE LA ROSSETE JJ, WIJKSTRA H et al: Is detrusor instability in elderly males related to the grade of obstruction? Neurourol. Urodyn. (1995) 14:625–633.
   PubMed Web of Science ®Google Scholar
• JOLLEYS JV, DONOVAN JL, KAY HEet al: Urinary symptoms in the community: how bothersome are they? Br. J. Urol. (1994) 74:551–555.
   Google Scholar
• PETERS TJ, DONOVAN JL, KAY HE et al.: The international continence society benign prostatic hyperplasia study: the bothersomness of urinary symptoms. Urol (1997) 157:885–889.
   Google Scholar
• ••This is a significant study about the impactof benign prostatic hyperplasia on quality of life.
   Google Scholar
• CHAPPLE CR, SMITH D: The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia. Br. J. Urol (1994) 73:117–123.
   PubMedGoogle Scholar
• ••This is the first study where the rationalefor combined treatment is reported.
   Google Scholar
• MICHEL MC, DE LA ROSSETE JJ: Efficacy and safety of tamsulosin in the treatment of urological diseases. Expert. Opin. Pharmaeother. (2004) 5:151–160.
   PubMed Web of Science ®Google Scholar
• STOEVELAAR HJ, VAN DE BEEK C, CASPARIE AF et al.: Treatment choice for benign prostatic hyperplasia: a matter of urologist preference? J. Urol (1999) 161:133–138.
   Google Scholar
• ROSSI C, KORTMANN BB, SONKE GS et al.: Alpha-blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it. J. Urol (2001) 165:38–41.
   PubMedGoogle Scholar
• MICHEL MC: Potential role of aradrenoreceptor subtypes in the etiology of LUTS. Eur. Urol (2002) 1 (Suppl.):5–13.
   Google Scholar
• ATHANASOPOULOS A, GYFTOPOULOS K, GIANNITSAS K et al.: Combination treatment with an a-blocker plus an anticholinergic improves quality of life in patients with bladder outlet obstruction. A prospective, randomized controlled study. Neurourol Urodyn. (2002) 21:308–309.
   Google Scholar
• PERLBERG S, CAINE M: Adrenergic response of bladder muscle in prostatic obstruction. Its relation to detrusor instability. Urology (1982) 20:524–527.
   Google Scholar
• PRICE D: Potential mechanisms of action of superselective alpha(1)- adrenoreceptor antagonists. Eur. Urol (2001) 40\(Suppl. 4):5–11.
   Google Scholar
• NOMIYA M, YAMAGUCHI O: A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoreceptor subtypes and their functional roles in human normal and obstructed bladders. J. Urol (2003) 170:649–653.
   PubMed Web of Science ®Google Scholar
• TAKAHASHI S, TAKEUCHI T, TOMITA K et al: The clinical efficacy of an alA/D blocker (naftopidil) on overactive bladder in patients with benign prostate hyperplasia. J. Urol (2004) 171\(Suppl. 4):356.
   Google Scholar
• ANDERSON KE, YOSHIDA M: Antimuscarinics and the overactive detrusor- which is the main mechanism of action? Eur. Urol (2003) 43:1–5.
   Google Scholar
• ••A review on the effects of anticholinergicson bladder function.
   Google Scholar
• ATHANASOPOULOS A, GYFTOPOULOS K, GIANNITSAS K et al.: Combination treatment with an a-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized controlled study. J. Urol. (2003) 169:2253–2256.
   PubMed Web of Science ®Google Scholar
• ••The first study with urodynamicassessment of combined treatment and evaluation of quality of life issues.
   Google Scholar
• NISHIMATSU H, HOMMA Y, KAWABE K et al: Efficacy of treatment with propiverine hydrochloride in patients on lower urinary tract function - BUP-4 tablets special study group II. Jpn. J. Urol Surg (1999) 12:857–867.
   Google Scholar
• ABRAMS P, KAPLAN S, MILLARD R: Safety of tolterodine in men with bladder outlet obstruction (BOO) and symptomatic detrusor overactivity. Eur. Urol (2002) 1(Suppl.):520.
   Google Scholar
• ••A significant clinical paper with a largenumber of patients to assess the safety of anticholinergics in the treatment of bladder outlet obstruction.
   Google Scholar
• KAPLAN SA, WALMSLEY K, TE AE: Use of muscarinic receptor antagonists as monotherapy in men with lower urinary tract symptoms who failed previous therapy with alpha blockers. J. Urol (2004) 171 (Suppl.) :243.
   Google Scholar
• SAITO H, YAMADA T, OSHIMA H et al.: A comparative study of the efficacy and safety of tamsulosin hydrochloride alone and combination of propiverine hydrochloride and tamsulosin hydrochloride in the benign prostatic hypertrophy with pollakisuria and/or urinary incontinence. Jpn. J. Urol Surg (1999) 8:525–536.
   Google Scholar
• SCHAFER W, WATERBAR F, LANGEN PH et al: A simplified graphical procedure for detailed analysis of detrusor and outlet function during voiding. Neuroura Urodyn. (1989) 8:405–409.
   Google Scholar
• LUCACS B, COMET D, GRANGE JC et al: Construction and validation of a short-form benign prostatic hypertrophy health-related quality-of-life questionnaire. BPH Group in General Practice. Br. J. Urol (1997) 80:722–730.
   PubMedGoogle Scholar
• OKADA H, SHIRAKAWA T, MUTO S et al: Propiverine hydrochloride relieves irritative symptoms of beningn prostatic hyperplasia. j Urol (2004) 171(Suppl.):357.
   Google Scholar
• LEE JY, KIM H, LEE SJ et al: Comparison of doxazosin with or without tolderodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int. (2004) 94:817–820.
   PubMed Web of Science ®Google Scholar
• HIRAYAMA A, FUJIMOTO K, MATSUMOTO Yet al: Positive response to ice water test associated with high-grade bladder outlet obstruction in patients with benign prostatic hyperplasia. Urology (2003) 62:909–913.
   PubMed Web of Science ®Google Scholar
• ANDERSSON K: Alphal-adrenoreceptors and bladder function. Eur. Urol (1999) 36\(Suppl. 1):96–102.
   Google Scholar
• WYNDAELE JJ: Commentary on practice point 'are symptoms of BOO and OABS relieved more effectively by doxazosin plus tolterodine than by doxazosin alone?' Nat. Clin. Pratt Urol (2005) 2:76–77.
   Google Scholar
• GERBER R, SCHUMACHER M, DOBRY E et al: Does bladder wall thickness correlate with bladder outlet obstruction in men and can it replace invasive pressure flow study? J. Urol (2004) 171(Suppl.):404.
   Google Scholar
• ATHANASOPOULOS AG, PERIMENIS PS: Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int. (2005) 95:1117–1118.
   PubMedGoogle Scholar